section 8
on 04 Oct 2013
Last Applicant/ Owned by
Babraham Hall
Babraham
GB
CB2 4AT
Serial Number
78178624 filed on 25th Oct 2002
Registration Number
3212165 registered on 27th Feb 2007
Filing Basis
1. intent to use
Disclaimer
NO DATA
Providing temporary use of online non-downloadable computer software for use in the design or identification and characterization of genes and proteins through bioinformatics related techniques; providing temporary use of online non-downloadable software for the design or identification of chemical entities for drug discovery research; providing temporary use of online non-downloadable computer soRead More
Providing temporary use of online non-downloadable computer software for use in the design or identification and characterization of genes and proteins through bioinformatics related techniques; providing temporary use of online non-downloadable software for the design or identification of chemical entities for drug discovery research; providing temporary use of online non-downloadable computer software for use in gene therapy and disease diagnosis; providing temporary use of online non-downloadable computer software comprised of algorithms for use in analysis and data-mining of sequence and chemical databases; providing databases and online databases featuring complementary peptide sequences to all known genes in the human, bacterial, viral, animal and plant genomes; proteomic, genomic, bioinformatics, chemical and scientific consultation services, namely, providing advice and consultation in the fields of genomics, informatics, study of protein properties molecular design; medical, scientific and biotechnological research, namely, identification and characterization of genes and proteins and the design or identification of chemical entities through bioinformatics and related techniques, and providing consultancy and advisory services relating thereto; consultancy, advice and provision of information relating to drug discovery research, disease diagnosis; design, creation and provision of databases, namely, databases for the identification and characterization of genes, proteins and small molecules; design and creation of computer software for data-mining; design, creation and development of proprietary informatics technology, namely for the location and definition of peptide and small molecule ligands; use of bioinformatics and related techniques to design the core regions of molecular functionality and to enable the generation, design, development and validation of peptide and small molecule ligands for existing and novel targets; prediction and design of peptides from DNA sequence data; data-mining operations; scientific research, namely, identification of targets for therapeutic applications and design of chemical inhibitors, agonists and antagonists; design, optimization and development of chemical inhibitors, agonists and antagonists for specific targets for therapeutic applications; design, creation and provision of informatics based programs designed to monitor and research scientific databases and identify potential leads matched to accompany discovery portfolio; genetic research services, namely, obtaining and analyzing genetic or chemical information; gene sequencing; laboratory research and collaboration with academic research groups in the field of drug discovery and healthcare research; pharmaceutical and bio technical research, namely, collaboration with pharmaceutical and biotechnology companies; drug discovery and development programs; synthesis of peptides and small molecules
Chemicals for use in the manufacture of pharmaceuticals, cosmetics, and healthcare products; chemicals for use in science, namely, reagents for scientific research; chemicals for use in biotechnology and chemicals produced through biotechnological processes, namely, therapeutic proteins and biologics for scientific use in drug discovery; peptide sand polypeptide and small molecules for use in scientific research; all of the aforesaid for use in assays, screens and diagnosis
Computer hardware; data processors; computer software for use in the design or identification and characterization of genes and proteins through bioinformatics and related techniques; computer software for the design and identification of chemical entities for drug discovery research; computer software for use in gene therapy and disease diagnosis; computer software comprised of algorithms for use in analysis and data-mining of sequence chemical databases
Pharmaceutical preparations for therapeutic, prophylactic and or pharmacological purposes, namely, for use in relation to abdominal disease, abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease, degeneration, dermatological disease, dystrophy, ear, nose, throat disease, endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder, genitourinary disease, growth disorder, hematological disease, immune disorder, immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological, mental and cognitive disorder, nutritional disorder, ocular disease, pain, pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder, somatosensory disorder, temperature disorder, toxicity and intoxication, ulcer,uterine motility; pharmaceutical preparations comprised of peptides and polypeptides for use in relation to abdominal disease, abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease, degeneration, dermatological disease, dystrophy,ear, nose, throat disease, endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder, genitourinary disease, growth disorder, hematological disease, immune disorder, immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological, mental and cognitive disorder, nutritional disorder, ocular disease, pain, pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder, somatosensory disorder, temperature disorder, toxicity and intoxication, ulcer, uterine motility; chemicals for use in biotechnology and chemicals produced through biotechnological processes, namely, vaccines
No 78178624
No Service Mark
No 071279.0103
No
No
No
No
No
No
No
No
26.09.02 -
Plain single line squares
26.17.10 -
Zig-zag line(s)
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
The mark consists of a stylized letter P in the color purple inside a square outlined in the color purple.
| Status Date | Action Taken |
|---|---|
| 04th Oct 2013 | CANCELLED SEC. 8 (6-YR) |
| 29th Jan 2009 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 06th Jan 2009 | ASSIGNED TO PARALEGAL |
| 20th Nov 2008 | TEAS SECTION 7 REQUEST RECEIVED |
| 27th Feb 2007 | REGISTERED-PRINCIPAL REGISTER |
| 11th Jan 2007 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 18th Dec 2006 | NOTICE OF ALLOWANCE CANCELLED |
| 18th Dec 2006 | TEAS DELETE 1(B) BASIS RECEIVED |
| 21st Jun 2006 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 20th Jun 2006 | EXTENSION 1 FILED |
